Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Digest.
Press releases published on May 19, 2025
Rani Therapeutics Announces Research Agreement with Chugai
GlobeNewswire
·
May 19, 2025
- Research agreement is evaluating feasibility of applying Rani’s oral delivery technology to Chugai’s antibodies against undisclosed targets - SAN JOSE, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “ …
Reflect Scientific Strengthens Position in Booming AI Data Center Cooling Market with Patented Cryogenic Innovations
GlobeNewswire
·
May 19, 2025
OREM, Utah, May 19, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a pioneer in cryogenic cooling technologies, today highlighted how its patented solutions are uniquely positioned to address the surging global demand for advanced data …
Keros Therapeutics Highlights Commitment to Maximizing Stockholder Value
GlobeNewswire
·
May 19, 2025
Files Investor Presentation and Issues Open Letter to Stockholders Urges Stockholders to Protect the Value of Their Investment by Voting “FOR” Each of the Company’s Highly Qualified Director Nominees LEXINGTON, Mass., May 19, 2025 (GLOBE NEWSWIRE) -- Keros …
Critical Metals Corp Releases Further Excellent Deep High-Grade Drilling Results on Tanbreez (TREO 0.48% & HREO 27%)
GlobeNewswire
·
May 19, 2025
NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Critical Metals Corp. (Nasdaq: CRML) (“Critical Metals Corp” or the “Company”), a leading critical minerals mining company, is pleased to publish for the first time the assay results of historical deep diamond …
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
GlobeNewswire
·
May 19, 2025
First XLRS study to demonstrate efficacy and positive safety data in a Phase I/II trial Majority of patients demonstrated successful efficacy readouts across structural measurements (foveal schisis closure) and had meaningful improvement on visual function …
Altimmune Announces Initiation of RECLAIM Phase 2 Trial Evaluating the Efficacy and Safety of Pemvidutide in Alcohol Use Disorder (AUD)
GlobeNewswire
·
May 19, 2025
GAITHERSBURG, Md., May 19, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced that it has enrolled the …
Gilat Reports First Quarter 2025 Results
GlobeNewswire
·
May 19, 2025
Revenues Increased 21% Year-over-Year with Adjusted EBITDA of $7.6 Million Reiterates Guidance for 2025 PETAH TIKVA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite …
XORTX Announces USD $3 Million Offering
GlobeNewswire
·
May 19, 2025
CALGARY, Alberta, May 19, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive …
Recommended A$0.08 Per Share Cash Offer
GlobeNewswire
·
May 19, 2025
TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) (Xanadu or the Company) and Bastion Mining Pte Ltd (Bastion) are pleased to announce that they have entered into a Bid Implementation Agreement on 19 May 2025 under which Bastion …
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
GlobeNewswire
·
May 19, 2025
LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA …
Pharvaris to Present Deucrictibant Clinical Data and Exploratory Biomarker Data at Upcoming Congresses
GlobeNewswire
·
May 19, 2025
ZUG, Switzerland, May 19, 2025 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such …
Mine Bitcoin Solaris on Your Smartphone: Nova App Private Beta Now Live
GlobeNewswire
·
May 19, 2025
TALLINN, Estonia, May 19, 2025 (GLOBE NEWSWIRE) -- Bitcoin Solaris today announced the launch of the private beta for its Nova App, a next-generation mobile mining platform that allows users to earn Bitcoin Solaris (BTC-S) tokens directly from their …
Teva Announces $2,000,000,000 (Equivalent) Debt Tender Offers For Notes Due 2026-2031
GlobeNewswire
·
May 19, 2025
TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it has commenced tender offers (the “Offers”) to purchase for cash for a combined aggregate purchase price (exclusive …
Teva Announces Launch of $2,000,000,000 (Equivalent) Offering of Senior Notes
GlobeNewswire
·
May 19, 2025
TEL AVIV, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today its intention to issue $2,000,000,000 (equivalent) of senior notes through its special purpose finance subsidiaries. Teva …
Formula Systems Files Annual Report on Form 20-F for the Year Ended December 31, 2024
GlobeNewswire
·
May 19, 2025
OR YEHUDA, Israel, May 19, 2025 (GLOBE NEWSWIRE) -- Formula Systems (1985) Ltd. (Nasdaq and TASE: FORTY) (“Formula” or the “Company”), a global information technology group engaged, through its subsidiaries and affiliates, in providing software consulting …
Das Intercom-Team schließt eine Vereinbarung mit FundedNext über eine exklusive Zusammenarbeit im Bereich KI ab
GlobeNewswire
·
May 19, 2025
AJMAN, Vereinigte Arabische Emirate, May 19, 2025 (GLOBE NEWSWIRE) -- Am 7. und 8. Mai empfing FundedNext eine hochrangige Delegation von Intercom unter der Leitung von Phil Moore (Head of Sales Engineering) und Ciaran Nolan (Senior Director, EMEA) zu …
فريق Intercom يتوجه إلى FundedNext لبحث التعاون الحصري في مجال الذكاء الاصطناعي
GlobeNewswire
·
May 19, 2025
عجمان، الإمارات العربية المتحدة, May 19, 2025 (GLOBE NEWSWIRE) -- استضافت شركة FundedNext يومي 7 و8 مايو وفدًا رفيع المستوى من شركة Intercom، بقيادة Phil Moore (رئيس هندسة المبيعات) وCiaran Nolan (المدير الأول لمنطقة أوروبا والشرق الأوسط وأفريقيا)، في إطار …
צוות Intercom טס אל FundedNext לשיתוף פעולה בלעדי בתחום הבינה המלאכותית
GlobeNewswire
·
May 19, 2025
עג'מאן, איחוד האמירויות הערביות, May 19, 2025 (GLOBE NEWSWIRE) -- בין ה-7 ל-8 במאי, FundedNext אירחה משלחת בכירה של Intercom, בהובלת פיל מור (מנהל הנדסת מכירות) וקיירן נולאן (מנהל בכיר, EMEA), לשיתוף פעולה ממוקד בן יומיים במרכז התפעול והתמיכה של FundedNext …
L’équipe d’Intercom en visite chez FundedNext pour une collaboration exclusive autour de l’Intelligence Artificielle
GlobeNewswire
·
May 19, 2025
AJMAN, Émirats arabes unis, 19 mai 2025 (GLOBE NEWSWIRE) -- Les 7 et 8 mai, FundedNext a accueilli une délégation d’Intercom, conduite par Phil Moore (Responsable de l’ingénierie commerciale) et Ciaran Nolan (Directeur général, région EMEA), pour deux …